top of page

ABOUT TRADECRAFT

Tradecraft Clinical Research is a life sciences consulting firm providing expertise in the Statistical Programming and Biostatistics disciplines for life sciences organizations. We partner with our clients to provide statistical analysis services for product development, regulatory submissions, and to assist in expediting the drug approval process. 

 

Our mission is to deliver high-quality, on-time deliverables in support of our clients' goals.

LEADERSHIP TEAM

Mike Willis

CEO

J. Kanan Sawyer, Ph.D.

Head of Communications

John Ilgenfritz

Vice President of Biostatistics 

As our CEO, Mike's focus has always been on keeping us accountable to our clients. His is a process-oriented leadership style that places ethics as our number one priority and follows it up with 22 years of experience in pharmaceuticals, a phenomenal set of technical skills, and a commitment to the exchange of ideas. He is also a PharmaVOICE 100 recipient! Contact

Kanan helps to keep us targeted on clear communication. She brings more than two decades of experience in communication training and presentation skills to the table and is simultaneously a tenured Associate Professor of Communication at WCU. (Plus, she keeps correcting our grammar!)

With going on 30 years of experience in the field, John’s statistical analysis expertise in the planning, analysis, and interpretation of clinical trials is beyond comparison. He knows the industry and focuses on clients’ needs with pinpoint precision.

Brittaney.png
Brittaney Ortland

Associate Vice President, Project Management

Brittaney is our Associate Vice President of Project Management. Her collaborative approach, attention to detail, and understanding of our clients’ goals help us maintain speed and transparency across our portfolio of projects. Her adept planning methods and flexible management techniques help us deliver greater value to our clients every day.

Karl.png
Karl Fischer

Vice President, Product Development & Software Strategy

With a focus on providing value to clients beyond our core Programming and Biostatistics Services, Karl is guiding our software strategy and leading efforts to develop the DataVIEWS clinical data analysis and visualization tool. We want to leverage the evolving open-source programming technology with CDISC data standards. This approach provides analysis results faster and enables visibility and insights into trial data as early and often as possible to aid decisions and improve the success rate and speed of drug development.

Matt.png
Matt Stroschein

Regulatory Business Advisor

Matt leans on over twenty years of experience building and innovating service businesses. He helps us develop strategic partnerships and implement modern strategies that align with emerging client expectations and support our company goals. His input helps us meet our clients’ needs today while preparing us to address the industry’s evolving requirements for the future.

PV100.png

Mike Willis, CEO was honored in the 2020 PharmaVOICE 100. These awards recognize the most inspiring people in the life-sciences industry and include leaders in research and development, marketing, technology, creativity, strategy, and medicine. They acknowledge individuals who positively impact their peers, their colleagues, their companies, their communities, as well as the industry at large through their actions.

bottom of page